공지 • Apr 27
Pharma Aids Limited to Report Q3, 2026 Results on Apr 29, 2026 Pharma Aids Limited announced that they will report Q3, 2026 results on Apr 29, 2026 공지 • Jan 26
Pharma Aids Limited to Report Q2, 2026 Results on Jan 29, 2026 Pharma Aids Limited announced that they will report Q2, 2026 results on Jan 29, 2026 공지 • Nov 10
Pharma Aids Limited, Annual General Meeting, Dec 24, 2025 Pharma Aids Limited, Annual General Meeting, Dec 24, 2025, at 11:30 Central Asia Standard Time. 공지 • Oct 31
Pharma Aids Limited to Report Fiscal Year 2025 Results on Nov 06, 2025 Pharma Aids Limited announced that they will report fiscal year 2025 results on Nov 06, 2025 공지 • Apr 28
Pharma Aids Limited to Report Q3, 2025 Results on Apr 30, 2025 Pharma Aids Limited announced that they will report Q3, 2025 results on Apr 30, 2025 공지 • Jan 23
Pharma Aids Limited to Report Q2, 2025 Results on Jan 30, 2025 Pharma Aids Limited announced that they will report Q2, 2025 results on Jan 30, 2025 Reported Earnings • Nov 12
Full year 2024 earnings released: EPS: ৳19.61 (vs ৳2.05 loss in FY 2023) Full year 2024 results: EPS: ৳19.61 (up from ৳2.05 loss in FY 2023). Revenue: ৳421.2m (up 37% from FY 2023). Net income: ৳61.2m (up ৳67.6m from FY 2023). Profit margin: 14% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. 공지 • Nov 12
Pharma Aids Limited to Report Q1, 2025 Results on Nov 13, 2024 Pharma Aids Limited announced that they will report Q1, 2025 results on Nov 13, 2024 New Risk • Nov 10
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 29% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Revenue is less than US$5m (৳409m revenue, or US$3.4m). Market cap is less than US$100m (৳1.92b market cap, or US$16.0m). Declared Dividend • Nov 09
Dividend of ৳2.50 announced Shareholders will receive a dividend of ৳2.50. Ex-date: 8th December 2024 Payment date: 23rd January 2025 Dividend yield will be 0.4%, which is lower than the industry average of 1.3%. Payout Ratios Payout ratio: 6%. Cash payout ratio: 11%. 공지 • Nov 07
Pharma Aids Limited, Annual General Meeting, Dec 24, 2024 Pharma Aids Limited, Annual General Meeting, Dec 24, 2024, at 11:30 Central Asia Standard Time. Valuation Update With 7 Day Price Move • Nov 04
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ৳694, the stock trades at a trailing P/E ratio of 42.6x. Average trailing P/E is 17x in the Packaging industry in Asia. Total returns to shareholders of 32% over the past three years. 공지 • Oct 31
Pharma Aids Limited to Report Fiscal Year 2024 Results on Nov 06, 2024 Pharma Aids Limited announced that they will report fiscal year 2024 results on Nov 06, 2024 Reported Earnings • Apr 26
Third quarter 2024 earnings released: EPS: ৳7.46 (vs ৳1.21 loss in 3Q 2023) Third quarter 2024 results: EPS: ৳7.46 (up from ৳1.21 loss in 3Q 2023). Revenue: ৳116.7m (up 39% from 3Q 2023). Net income: ৳23.3m (up ৳27.0m from 3Q 2023). Profit margin: 20% (up from net loss in 3Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings. 공지 • Apr 21
Pharma Aids Limited to Report Q3, 2024 Results on Apr 24, 2024 Pharma Aids Limited announced that they will report Q3, 2024 results on Apr 24, 2024 Reported Earnings • Jan 31
Second quarter 2024 earnings released: EPS: ৳7.21 (vs ৳0.76 loss in 2Q 2023) Second quarter 2024 results: EPS: ৳7.21 (up from ৳0.76 loss in 2Q 2023). Revenue: ৳120.8m (up 63% from 2Q 2023). Net income: ৳22.5m (up ৳24.9m from 2Q 2023). Profit margin: 19% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance. 공지 • Jan 26
Pharma Aids Limited to Report Q2, 2024 Results on Jan 30, 2024 Pharma Aids Limited announced that they will report Q2, 2024 results on Jan 30, 2024 Reported Earnings • Nov 14
Full year 2023 earnings released: ৳2.05 loss per share (vs ৳11.14 profit in FY 2022) Full year 2023 results: ৳2.05 loss per share (down from ৳11.14 profit in FY 2022). Revenue: ৳308.5m (down 4.5% from FY 2022). Net loss: ৳6.38m (down 118% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings. 공지 • Nov 09
Pharma Aids Limited Recommends Cash Dividend for the Year Ended June 30, 2023 Pharma Aids Limited Board of Directors has recommended 10% cash dividend for the year ended June 30, 2023. Date of AGM is December 28, 2023, Record date is December 07, 2023. 공지 • Nov 02
Pharma Aids Limited to Report Fiscal Year 2023 Results on Nov 07, 2023 Pharma Aids Limited announced that they will report fiscal year 2023 results on Nov 07, 2023 Reported Earnings • May 02
Third quarter 2023 earnings released: ৳1.21 loss per share (vs ৳4.63 profit in 3Q 2022) Third quarter 2023 results: ৳1.21 loss per share (down from ৳4.63 profit in 3Q 2022). Revenue: ৳83.8m (down 2.0% from 3Q 2022). Net loss: ৳3.76m (down 126% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 29% per year, which means it is well ahead of earnings. Reported Earnings • Jan 24
Second quarter 2023 earnings released: ৳0.76 loss per share (vs ৳5.53 profit in 2Q 2022) Second quarter 2023 results: ৳0.76 loss per share (down from ৳5.53 profit in 2Q 2022). Revenue: ৳74.2m (down 8.6% from 2Q 2022). Net loss: ৳2.36m (down 114% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings. Upcoming Dividend • Dec 04
Upcoming dividend of ৳5.00 per share Eligible shareholders must have bought the stock before 11 December 2022. Payment date: 26 January 2023. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of Bangladeshi dividend payers (3.8%). Lower than average of industry peers (1.9%). Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Aug 25
Investor sentiment improved over the past week After last week's 17% share price gain to ৳933, the stock trades at a trailing P/E ratio of 48.5x. Average trailing P/E is 39x in the Packaging industry in Bangladesh. Total returns to shareholders of 78% over the past three years. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Feb 02
Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations Second quarter 2022 results: EPS: ৳5.53 (up from ৳4.03 in 2Q 2021). Revenue: ৳81.1m (up 20% from 2Q 2021). Net income: ৳17.3m (up 37% from 2Q 2021). Profit margin: 21% (up from 19% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Valuation Update With 7 Day Price Move • Jan 22
Investor sentiment improved over the past week After last week's 26% share price gain to ৳791, the stock trades at a trailing P/E ratio of 45.9x. Average trailing P/E is 15x in the Packaging industry in Asia. Total returns to shareholders of 23% over the past three years. Valuation Update With 7 Day Price Move • Dec 28
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ৳561, the stock trades at a trailing P/E ratio of 32.5x. Average trailing P/E is 14x in the Packaging industry in Asia. Total loss to shareholders of 3.4% over the past three years. Upcoming Dividend • Dec 01
Upcoming dividend of ৳5.00 per share Eligible shareholders must have bought the stock before 08 December 2021. Payment date: 30 January 2022. Trailing yield: 1.0%. Lower than top quartile of Bangladeshi dividend payers (3.1%). Lower than average of industry peers (2.1%). Is New 90 Day High Low • Feb 15
New 90-day low: ৳393 The company is down 6.0% from its price of ৳418 on 17 November 2020. The Bangladeshi market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Packaging industry, which is flat over the same period. Is New 90 Day High Low • Dec 20
New 90-day high: ৳472 The company is up 1.0% from its price of ৳468 on 21 September 2020. The Bangladeshi market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Packaging industry, which is down 6.0% over the same period. 공지 • Nov 11
Pharma Aids Limited, Annual General Meeting, Dec 24, 2020 Pharma Aids Limited, Annual General Meeting, Dec 24, 2020, at 11:30 Bangladesh Standard Time. 공지 • Nov 10
Pharma Aids Limited to Report Q1, 2021 Results on Nov 12, 2020 Pharma Aids Limited announced that they will report Q1, 2021 results on Nov 12, 2020 공지 • Jul 06
Pharma Aids Limited to Report Q3, 2020 Results on Jun 24, 2020 Pharma Aids Limited announced that they will report Q3, 2020 results on Jun 24, 2020